The analysis of TCGA tumor patient data revealed that high CES1 expression was associated with poor prognosis in various types of tumors including adrenocortical carcinoma, bladder cancer, HNSCC, lung squamous cell carcinoma, and hepatocellular carcinoma (Fig. 3A). This evidence concerns the gene CES1 and adrenal cortex carcinoma.